CYBN

FartingOnAMetalChair

Curious what you think about this CYBN news, will it cause massive dilution? [https://www.tipranks.com/news/the-fly/cybin-initiates-at-the-market-equity-program-of-up-to-100m-thefly](https://www.tipranks.com/news/the-fly/cybin-initiates-at-the-market-equity-program-of-up-to-100m-thefly)

ElectronicSea7975

Been a while since I researched, but if memory serves CYBN was one of the leaders in FDA trials of LSD for PTSD treatment. I believe they were also pursuing treatment of LSD and other psychedelics for depression. Specifically, people with depression that SSRI's did nothing for. Another company to look into is ATAI. Backed by Peter Thiel. Their model was 1) inorganic growth by acquiring a lot of other psychedelic businesses and 2) pursuing a patent on synthetic psilocybin molecule. Peter Thiel gave a talk a couple years ago at Davos about psychedelics. Right now there's a lot of pie in the sky with psychedelic stocks, but if these businesses can achieve what they're pursuing: gold mine.

AnyInjury6700

$CMPS, $ATAI, $CYBN - Psychedelic medicine is the mental health breakthrough the world needs.

AnyInjury6700

Patented synthetic psilocybin polymorph (unique crystalline structure) going through FDA clinical trials. It's currently in the second Phase 3 trial, the final stage before potential approval. On top of that you have bipartisan support in Congress, RFK Jr publicly advocating for it, and the head of the FDA himself has said we need to be looking into these compounds. Lastly, FIVE  of these compounds now have Breakthrough Therapy designation which further accelerated approval and massively raises approval chances. Psychedelic Drugs with FDA Breakthrough Therapy Designation 1. CYB003 (Deuterated Psilocybin analog) - $CYBN (soon to be $HELP) A novel psilocybin-derived compound developed by Cybin for major depressive disorder (MDD). Received Breakthrough Therapy designation from the FDA. Designed to have a faster onset and shorter duration than classic psilocybin. Currently in advanced clinical trials (Phase 3) for MDD. � Wikipedia +1 2. MM120 (LSD-based compound) - $MMED A specially formulated LSD-derived drug being developed by MindMed for generalized anxiety disorder (GAD). Granted Breakthrough Therapy status based on promising clinical data. � Forbes 3. Psilocybin (COMP360; various formulations) - $CMPS Psilocybin itself has received Breakthrough Therapy designations through specific company programs (e.g., COMPASS Pathways’ COMP360 for treatment-resistant depression and Usona Institute’s psilocybin program for major depressive disorder). These designations date back to earlier in the decade and continue to support ongoing Phase 3 research. � Grass Roots NLP +1 4. 5-MeO-DMT (BPL-003) - $ATAI A novel intranasal formulation of 5-MeO-DMT developed by Atai Life Sciences and Beckley Psytech has recently been reported to receive FDA Breakthrough Therapy designation for treatment-resistant depression. This reflects growing interest in rapid-acting psychedelic treatments beyond psilocybin and LSD. �

AnyInjury6700

I apologize, I was referring to Cybin, currently $CYBN They are rebranding soon to Helus Pharma with a new ticket $HELP I'm not really a fan of the rebrand, but their patent portfolio/clinical pipeline is incredible. Deuterated psilocin and deuterated NN-DMT. The DMT trial demonstrated that patients who stayed on their SSRIs actually had BETTER remission rates than those who got off them. This was unexpected and is a massive boon for patients.

Standard-Setting7318

CYBN and SPRC moving nicely AH

AnyInjury6700

$ATAI and $CYBN for short acting clinical psychedelics

CompatibleDowngrade

Also long CYBN in addition to CRSP and BEAM. Probably going to index though going forward because it’s hard to pick winners!

0mlu

Waiting for CYBN to take off

DDPStellar

CYBN*

Ok-Conversation6225

PSTV SHOT RVPH IVDA. MYSE and CYBN are my longer term ones.

mcfilms

In the early 2000s I started DCA investing into an IRA. I bought Netflix when they were only mailing DVDs, Apple when they were beat down, and a new electric car company called Tesla. I also put some money into QQQQ and other funds. As the individual stocks beat the market, I decided I was great at picking winners. So over time I invested in a US flatscreen TV maker (Syntax-Brillian) that went to zero, a solar panel company that died, a promising pharmaceutical company that got bought out for pennies right before BK, and a video game engine (U) that made a couple horrible acquisitions (currently down 35%). During that time, I bought into these companies as they dropped, rarely catching that falling knife. Turns out, I'm not Warren Buffet. These days I mostly invest in VTI and QQQ. I do occasionally invest a small amount into long shots like Rivian and CYBN, but mostly treat that like gambling. I regret those early wins, because they got me high on the smell of my own farts. Maybe SOME can beat the index funds, but that ain't me.

BermudopeHighangle

Holy hell CYBN

Much-Creme1362

Two stocks: PSIL CYBN

BermudopeHighangle

The volume on psychedelic stocks is crazy. PSIL ATAI CMPS CYBN are bout to blow

BermudopeHighangle

Psychedelic approvals must be coming with this volume ATAI PSIL CMPS CYBN

BermudopeHighangle

Continuing to buy psychedelic stocks, per usual. PSIL ATAI CYBN CMPS

BermudopeHighangle

Psychedelics approval is all but guaranteed with this administration and you’re going to miss the boat ATAI CYBN CMPS PSIL

BermudopeHighangle

Shroom stocks beating the odds today ATAI CYBN CMPS

BermudopeHighangle

CYBN going $7 —> $150 Set and forget

BermudopeHighangle

CYBN going $7 —> $150 Set and forget

BermudopeHighangle

Daily shroom stock shill CMPS CYBN

BermudopeHighangle

CMPS and CYBN help my IRA reach enlightenment

HotWeek3110

MNMD Mindmed and CYBN Cybn both late stage psychedelics for mental health

HotWeek3110

MNMD Mindmed and CYBN Cybn - psychedelics for mental health

stakattack90

CYBN?

twiggs462

Most of them are crap. ATAI, MNMD and CMPS will be the horses here. ATAI never went through its cycle. MNMD was shit until the new CEO took over, CMPS only because CYBN is a joke.

ReadingWise6386

CYBN, not a pennystock by stock price but massively undervalued. strongesg psychedelic play IMO and phase 2 data soon

educ8inokc

CYBN, end depression and dependence on pharmaceuticals.

gosumage

No idea. I have been holding CYBN for a long time, but I just consider it a lottery ticket that might pay off one day.

SubtleRedditIcon

MNMD or ATAI with their BioPharm stuff. MNMD got a breakthrough therapy designation for Generalized Anxiety Disorder on their MM120 drug from the FDA not long ago and was already working with consultants on how to approach their phases. And now, the FDA just changed their ways and said that instead of just telling companies they failed the phases/tests/approval, they are now telling them EXACTLY why they failed. So, in the terms of these BioPharm companies that have been working to get their drugs approved and to the market, they know will have sufficient information to go back on should they fail in their approvals. MNMD seems to be the champion here right now as their growth is actually not too bad for a company with no drugs to the market just yet. There have been expansions in the company's size, they have worked with consultants from the FDA, from a variety of healthcare industry leaders, and also Big Pharm companies. ATAI is a similar company, using a different compound for GAD and social anxiety. However as of now I think they are in the process of phase 2, where as MNMD is in phase 3 with one pipeline and almost done 2 with another. I'm sure these 2 have been tossed around in the likes of Compass (CMPS) and Cybin Inc (CYBN) although I think CYBN might be out of the picture and working on patents in England last I heard? Don't quote me. I have really been watching MNMD for years and more recently paid attention to ATAI. I think this sector is getting a ton of attention now with veterans speaking out of their experiences with psychoactives and therapy. The government is loosening up it's grip and is seeing this as an industry. Both are cheap enough to get a few shares, stash, see what they move like and evaluate your position in a year.

cr00ked87

CYBN 🚀🚀🚀🚀

amacen87

I have 11 shares of CYBN... I know it's not a lot, but I bought them at $14.63, and now they are at $8.02... Maybe because of potential government regulations? Should I just keep them and wait until I lose all my money?

gosumage

Lots of potential with these substances, but nothing will happen to the stock prices until rescheduling and FDA approval. They are obviously far superior to SSRIs. I hold a a couple hundred shares of CYBN as a lotto ticket. I think their dDMT (CYB004) has the most chance for commercial success. 20 minute trip vs 4-6 hours on psilocybin and 10 hours with LSD. I'll also just note that I've done all three, and DMT was the only one that resulted in noticeable positive behavioral changes (for me). Of course, they all grant amazing experiences regardless of the antidepressive effects. But it means nothing until rescheduling. And despite RFK's (dear god save us) and Casey Means' (new Surgeon General) support of psychedelic therapy, I would give it a less than 5% chance of actually happening during this Trump admin. They can't even get medical marijuana right, they will never go for psychedelics which have been demonized by government propaganda for decades. Not to mention Elon's supposed ketamine abuse has just turned psychedelic therapy into a meme at this point. In the same bill, Florida has also just banned not only fluoride in water but psychedelic mushroom spores which of course contain zero psilocybin effective July 1. Never. Gonna. Happen. Not with these religious nutjobs running the government. Medical studies mean absolutely nothing to them.

Appropriate-Hunt-897

CYBN CMPS ATAI MNMD there ya go

scoobysnacks1

Psychedelic stocks are heating up. CMPS, ATAI, CYBN. Get em while they are cheap. 10 baggers end of this year

ItsHew

Holding CYBN. Need something better to put it into

gosumage

He is a supporter of psychedelic and disassociative assisted therapy (psilocybin, MDMA, LSD, ketamine) So stocks CYBN and MNMD will benefit with increased odds of approval/rescheduling.

mskabocha

My smooth brain DD on CYBN is MNMD pumped and so will it cause same sector 

DDPStellar

CYBN

RIVERSIX6

PSYCHEDELICS are fire. ATAI MNMD CMPS CYBN IXHL SILO CMND MDMA TRIP

cryptohick

I grab a few more CYBN every time they dip. I think their patents give them a unique advantage in the space, ultimately allowing future pharma and insurance to look more favorably on its application The space also stands to see movement depending how the new US administration takes shape and what sort of emphasis (if any) will be placed on psychedelic therapies

Fre3ReFills

I believe strongly in the Psychedelic Biotech stocks; CMPS, ATAI, CYBN, MNMD. These companies' drugs, along with assisted therapy, are used to help with various mental health issues, anxiety, and addiction and depression which is at an all-time time high, roughly 30% of ppl. https://news.gallup.com/poll/505745/depression-rates-reach-new-highs.aspx With the news about SSRI's in the last few years, I believe we need a new treatment solution. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0265928 https://adaa.org/learn-from-us/from-the-experts/blog-posts/professional/just-antidepressants-dont-work-anymore https://pmc.ncbi.nlm.nih.gov/articles/PMC6001865/ I started to research psychedelic therapy when I saw an interview with Johns Hopkins Roland Griffiths years ago. He talked about his study of giving End Of Life Cancer Patients Psychedelic Medicine and how it changed their life. Back in 21' I was lucky enough to invest in MNMD when it was a penny stock on the NEO at $.0.30 and within a year, it ballooned to over $5.50+. I diversified those profits into other companies. Since then, they all have crashed hard. Iv been slowly getting more and lowering my average cost. These companies are now in Phase 2 and some in Phase 3 trials and everything they have released data it was been very very promising. I'm hoping for a strong 2026 and beyond.

VinoVoyage

CYBN

LilPrinceTrashMouth

Analyst seem bullish on CYBN. Might buy LEAPS.

Ok-Savings2625

Lol, I've been there, I wasn't expecting to see these prices for SMR until at least 2026. The markets are cyclical, and nuclear is in the spotlight along with A.I. The whole markets are artificial right now and may likely plummet by +50% in the next coming years. Not financial advice at all because I'm nobody, but the health sector is long overdue in America. I have my biggest positions in CYBN and PSIL, aside from crypto. I know from experience the benefits of psilocybin in treating disorders. With RFK being in the administration, the psilocybin play seems like a no-brainer. Or all brainer? Idk

NewDoah

CYBN and VCEL. CYBN is a bit of a long shot but their trials have looked promising. Also AA

Cheeselic

This aged poorly lol, a month later CYBN hit a 2000% gain.

MtTime420

$MNMD, $ATAI, $CYBN Maybe all these? https://preview.redd.it/7udp9m6m0k4e1.jpeg?width=1170&format=pjpg&auto=webp&s=db87b4d4f416ddaed546108cca9d644d23f78a51 …and more!

MtTime420

Here’s the volume leaders on the watchlist I call “Mind”. It contains cannabis and psilocybin companies. I have positions in $TLRY, $ACB, and an OTC CBD company called $CBDD. I’ve had positions in $MMND, $CYBN and $ATAI. I do believe $HITI and $SNDL have the most room for growth, $TLRY could fall hard if the SEC ever investigates all the Hindenburg Research posts from 5-6yrs ago but basically they are a brewery company now, but I do think the trifecta of $MNMD, $CYBN and $ATAI could move the most if RJK gets his way. I believe people are tired of the scammy nature of cannabis companies, especially the knee originating out of Canada.

Recent_Register_2952

$CYBN

iamhannimal

NFA: 1.03 average here. I’m currently in the industry but not an “insider” at any company. I’d grab some below 2 and add chunks when it dips. Same with clearmind (1.31 average). Smaller positions: lobe, Awaken, tryptamine, optimi. Sold MNMD. Need to see better decisions from the company before I buy back in. CMPS is a buy right now I’d say. Under 4.50 is a steal long term. CYBN im cautiously adding (no longer a penny stock though). Treating it like one.

GodMyShield777

CYBN a 200m cap , quite different than CTM . But just look at history , a reverse split almost always drops the stock price . Either before or after it happens That being said , I'm currently loving the entry point in Castellum. No risk it no biscuit , am I right ? Since you followed the chart on this . Should I get in during pre-market tomorrow ? I'm trying to catch it early if there's a run . Or wait a bit till regular market open , see how things shake and bake before entering

wavychaser

Yeah I feel you - that is/was my first and only real concern, but I've definitely invested in riskier. I maintain that the RS doesn't change the value of the stock and if the company is doing alright, it wouldn't change much - if retail wants to sell that's on them. For example, $CYBN is relatively stable after their RS and they are not even revenue-generating at this point, not even close, still just an idea... I've seen sell-offs, I've seen dips, and I've seen them get bought back up too. Algorithms have been gobbling shares from $.15-.17, sometimes getting lucky filing down to $.12 (if only I had been there then...). There are shorts who will be dying to get these shares. The [\~500,000 shares that are still short from 2 days ago](https://fintel.io/ss/us/ctm) could be trapped below $.1740 if you look at the high of the day two days ago, 11/26; the longer they go, they will start contributing to the buying pressure too... I have no idea why they were playing around taking out more yesterday, expecting to flip this for a penny.

Ok-Alternative-7462

Well, I see many are panic selling. I’m bullish on my psychedelic stocks because I believe in their powers of healing childhood trauma and PTSD. Not recreation, but for a therapeutic purpose. I have extensively studied research on the effects of MDMA and PTSD amongst veterans. My CYBN, ATAI stocks are up!

BigWarning8696

HUT, WULF, CLSK: I think the cost-efficient crypto miners will have very good earnings next ER MNMD/CYBN: these psychedelic stocks should get a lot of hype once new presidential term starts TLN: partnership with AMZN will be a big catalyst and nuclear is a good sector to be in VKTX: looks like chart is bottoming out and any good news should really make it pop, but sector has fallen out of favor.

Recent_Register_2952

$CYBN to the mooooooon

ShallotSignificant76

Don't worry, RFK Jr. will treat it with a few rounds of chelation and psychedelics. Buy $CYBN.

P_A_N_C_H_O__

Ok very quick research, company has 6 months left of cash, 3.7M, spending a cash burn of 1.8M per Q. So basically if you are spending 1.8M per Q you are: A) not developing any AI B) not developing anything. A clinical development process costs millions. Plus, its not even shorted, it wont squeeze, the data you are looking say nothing by itself, word of advice dont chase squeezes. Almost no one here understands how a squeeze really work. Share for shorting availability says nothing by itself, and actually in most cases a low availability signals it is not squeezable (if thats even a word) This IS financial advice: stay away from this one. If you want to check out some companies with potential Pennies: RBOT, QUBT, CYN, ARQQ, QBTS, CYBN, ABOS, RGTI Mid cap: PATH, PARA I recommend using DilutionTracker.com to check cash position on pennies before even doing more research. All Quantum stocks are getting a lot of interest, QUBT being the most bought, I bought it at 1 and the lowest was I believe .40 cents, closed yesterday above 4. Did an offering now so it will pull back considerably. This is NOT financial advice, just some examples of stocks I like and have positions, small in some and very large in others, do your own research.

SoManyHats

Been a hell of a week for ATAI and CYBN. You think it’s just because of the election and RFK’s pro psychedelic stance or did I miss some other big news?

WeedMillionaire

Well the whole point of RFK is that he is against patents to Pharma so the drug component might have less importance. If anything MAPS/LYCOS which was denied by the FDA might just get approved because its about the process rather than the formulation itself. There is a reason why Rick Doblin is an advisor to Numinus. And every other company CMPS CYBN MNMD also works with Numinus to run their trials so they have first dibs when it will be time to provide the therapy. The drug itself will only likely cost 300$-500$ versus the therapy which will be in the 15K$-20K$ range. Big money will be in the therapy, without the therapy the drug is useless.

ntovi

Psychedelic-focused biopharm innovators - CYBN, MNMD, ATAI, & CMPS. Exciting catalysts and fed support inc

Senior-Purchase-538

$MNMD is the ticker. What else psychedelic is good to hold? $CYBN? Both got hundreds of millions cash runway.

BigWarning8696

CYBN should also do well. I'm not sure which will do better, so I bought a bit of both for a long hold

BigWarning8696

The psychedelic stocks will do very well in the next presidential term. MNMD CYBN

SubtleRedditIcon

I say hang on to CYBN with that price! I keep upping my positions on both when I can and if the price is kind of stagnant. Based on researching these companies through the years, and more recently checking other companies that got the FDA Breakthrough Therapy designations, it just seems logical that these both will exceed $20 a share easily. And any success from phase 3 is going to have eyes on them from Big Pharma so then it gets even more exciting.

SubtleRedditIcon

Hey! Sorry for the delay. I actually hold a ton of CYBN as well, but more of MNMD! They both have amazing potential to grow and change the BioPharma industry. Both have the FDA Breakthrough Therapy designation on one of their developing drugs, both have significant results on Generalized Anxiety Disorder, and both have insanely talented individuals working for them. So why MNMD over CYBN? I think simply because of the current price of each. MNMD to me has a much bigger room for growth. Their target price has consisently gone up, while CYBN has just slightly. MNMD also has been raising funds and more shares have been issued with a lot of it going to insider buying. Both companies have had issues with downturn in pricing and splits but that to me is more indicative of the market. Look at them and any other start-up pharma that's about 5-6 years old and you'll see similar movement. I'm sure they both will have success if FDA approved, but MNMD feels like it will have a bigger boom in pricing given it's current price and comparative growth from previous FDA Breakthrough Therapy designated drugs (Check that out! The success rate of drugs with the designation are really high.).

brokedown-wook

CYBN

zzzzzz808

CYBN psychedelic biopharm

Surador

you have no clue about the market if you pitch CYBN. if you take one look at their debt and cash burn you will see

Blazzer675

I really think psychedelics are a huge breakthrough for mental health though. I’d like to hear other people opinions though. Does anyone know any stocks that have made progress already? I know CYBN is a big one but not much news from them. This would be for long term I know it’s not a big market now.

RollingMeteors

> $CYBN What's wrong with this stock? What are you expecting this stock to have done? What cannabis stocks would you not consider shitty and for what reasons?

MtTime420

Awesome - thanks for this news. Finally offloading this shitty stock. It’s getting as pathetic as $CYBN.

icallitadisaster

CYBN

MtTime420

“For over a year”… waiting…will be waiting…may always be waiting…. That, ladies and gentlemen, is exactly how NOT to invest. There are stocks, options, hell even bonds, that have more price action than $CMPS, $ATAI, and now after the RS, $CYBN. Patents don’t mean shit. Patience isn’t a virtue. Dumb money stays with stocks like this. Smart money sells, buys other things with that capital, and reinvests when there are actual news catalysts and actual price movement. Until then, it’s called a tortured investment. These “leaders” want to yo think they have something investable when they know they don’t. Otherwise they would. This is not the FDA. This is the competency of these companies and the cash they can generate. It didn’t take $JNJ a decade to bring Spravato to market. That should tell you all you need to know about the future of this industry. $JNJ and the FDA brought a ketamine “treatment” to market inline with $JNJ baby talc scandal. So when you wonder, in a year, what’s going on with these companies…I sure hope you remember this post and not listening to podcasts of those “leaders” (that don’t lead). Doug Drysdale of $CYBN is a perfect example of a leader you never want to follow.

LackOfStack

Is CYBN not considered a penny stock any more with the reverse split? I’m enjoying the rally.

MtTime420

Add $CYBN to that list.

icallitadisaster

CYBN

Ou_deis

Here's a specific example you can check for yourself: CYBN has announced a reverse stock split to take place on September 19th. But I don't see anything about that on Tradingview or eTrade. And eTrade says, "There is no news available for "CYBN"." Searching for CYBN on Yahoo Finance turns up no results about the upcoming split---although something seems to be seriously wrong with Yahoo Finance's symbol search because Yahoo Finance does have an article from Tipranks titled "Upcoming Stock Splits This Week (September 16 to September 20)" which lists the CYBN reverse split. You can see for yourself: [Cybin Inc. (CYBN) Stock Price, News, Quote & History - Yahoo Finance](https://finance.yahoo.com/quote/CYBN/) [Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested (yahoo.com)](https://finance.yahoo.com/news/upcoming-stock-splits-week-september-133837938.html)

Ohculap

Check out HUMA and CYBN

MtTime420

And also remember that anxiety and excitement are the same emotion. Perception and perspective are everything. Philosophical waxing aside… I have a position. Having gone through the $ICU and many other RS, with $CYBN approaching next Friday… it’s my belief that we ask questions and watch the chart until we hold our own thesis about a position. Thats all. I do believe the dilution is behind them, warrants are accounted for, the books are sound, and agree that the revenue stream looks pretty damn amazing. Oh, and there’s that chart ;)

MtTime420

MDMA “failing”, $CYBN and their reverse split, and now this is pushed to December…conveniently AFTER the election. This is very concerning. The U.S. government and economy is propped up by debt and specifically debt tied to massive leverage…often used for biotech companies. The government cannot allow something that grows in everyone’s backyard to become the de facto monopoly on patient health. Because they know herb is just that, an herb. It’s medicinal, mental health benefits, treatments for so many ills that plague American society…that they know (I’m talking to you FDA) that federal legislation and the pharmaceutical company slaughtering will effectively kill our economy. As long as hedge funds offer leverage we won’t see the federal government legalize marijuana. Mark my words.

fowells

After disappointment with $CYBN doubling down on $KULR and $VHAI

fowells

Well I was wrong about $CYBN, stupid RS 

MacSteele13

CYBN... hope springs eternal.

Gullible_Adagio4026

A little bit more about [CYBN](https://borncrisis.com/articles/should-i-buy-cybn-stock-now/) I wouldn't buy it now unless FDA approval is seeming increasingly likely. 

Bossie81

Yeah? [https://www.sec.gov/edgar/search/#/ciks=0001833141&entityName=CYBIN%2520INC.%2520(CYBN)%2520(CIK%25200001833141)](https://www.sec.gov/edgar/search/#/ciks=0001833141&entityName=CYBIN%2520INC.%2520(CYBN)%2520(CIK%25200001833141))

fowells

https://preview.redd.it/vtlnbxizlgkd1.png?width=803&format=png&auto=webp&s=6b77a2280627659f12ff5db5070fed0aa489acfb $CYBN week see that end of day trend each day, there are some insider actions being taken

fowells

https://preview.redd.it/vcmab1uvlgkd1.png?width=798&format=png&auto=webp&s=6d8556fbdf5910251fed4333b4b3af44745c4b80 $CYBN month

fowells

$TELL is startingit's decline, $CYBN is starting it's rise. WIthin September/October sell off all $CYBN and buy some $TELL if my crystal ball is workign correctly.

Gullible_Adagio4026

Read about [CYBN](https://borncrisis.com/articles/should-i-buy-cybn-stock-now/) and how it relates to Lykos's failed phase 3s... Don't invest more money than you can afford to lose 100% in any psychedelic company. 

MtTime420

How did you determine the Citadel equal calls and puts - thanks for the finviz link but I couldn’t determine the call/put ratios. Feel like a stock to watch when Citadel is manipulating both sides. As always, appreciate your thorough DD…and like you did in the $CYBN post you submitted (excellent work BTW!), you seem like you try and remain fair on your analysis and are transparent about the bad things happening too. A workforce reduction can be a sign of bad times, but feels like companies employ that now to increase earnings over the subsequent quarters.

dustindh10

Just started on Thursday with my $1350 rollover from a previous employer. Went hard($1k) into INTC and have pending orders for CLOV($300) and CYBN($20) after reading through the posts today... lol.

WalterWhiteBoy16

$CYBN Cybin looks way more promising. They have over 100 patents and have been granted a Breakthrough Therapy Designation by the FDA for their CYB003 psilocybin drug that goes into phase 3 clinical trials next month. Their phase 2 results showed CYB003 was 7x more effective at treating depression than SSRI’s. The BTD allows them direct access to plan the trial with the FDA guidance so they know exactly what they need for approval.

fowells

$CYBN, Septmber is coming! [https://www.businesswire.com/news/home/20240813535574/en/Cybin-Announces-Completion-of-FDA-Type-B-Initial-Breakthrough-Therapy-Meeting-and-Plans-for-CYB003-Phase-3-Program-in-Major-Depressive-Disorder](https://www.businesswire.com/news/home/20240813535574/en/Cybin-Announces-Completion-of-FDA-Type-B-Initial-Breakthrough-Therapy-Meeting-and-Plans-for-CYB003-Phase-3-Program-in-Major-Depressive-Disorder)

fowells

Good luck to you, sold off another 300 today to buy in more with $CYBN, if we don't both make money I hope at least one of us does 

fowells

$CYBN, looking for a good return by weeks end with the conference, if not September brings a jump every year.

fowells

Not as well as expected, I sold off 300 shares to dump them into $CYBN, after their conference tomorrow and Wednesday I'm hoping for a significant jump. Like 20% is enough to get me excited but could be more.

_FIRECRACKER_JINX

CYBN I bought the dip earlier this year.

fowells

$CYBN pattern jump in September/October